The infectious diseases pharmacist: An essential partner for health-system leadership in keeping pace with the coronavirus disease 2019 (COVID-19) pandemic

Overall, 71 presentations, >1,000 items were presented, including peer-reviewed articles, variant surveillance data, press releases, Food and Drug Administration releases, National Institute of Health updates, emergency use authorization (EUA) updates, internal drug utilization trends, system COVID-19 therapeutic optimizations (eg, creation or edits of electronic order sets and workflows). CDC, Centers for Disease Control and Prevention; COCA, clinician outreach and communication activity; EUA, emergency use authorization; FDA, Food and Drug Administration; NIH, National Institutes of Health. [...]the health system has supported opening full-time equivalents for 5 additional infectious diseases pharmacists and 1 infectious diseases pharmacy resident during the pandemic.